Open access peer-reviewed chapter

Current Perspectives in Metastatic Renal Cell Carcinoma Treatment: The Role of Targeted Therapies

By V. Michalaki, M. Balafouta, D. Voros and C. Gennatas

Submitted: May 31st 2012Reviewed: November 5th 2012Published: February 13th 2013

DOI: 10.5772/54856

Downloaded: 740

© 2013 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution 3.0 License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to cite and reference

Link to this chapter Copy to clipboard

Cite this chapter Copy to clipboard

V. Michalaki, M. Balafouta, D. Voros and C. Gennatas (February 13th 2013). Current Perspectives in Metastatic Renal Cell Carcinoma Treatment: The Role of Targeted Therapies, Renal Tumor Jindong Chen, IntechOpen, DOI: 10.5772/54856. Available from:

Embed this chapter on your site Copy to clipboard

<iframe src="http://www.intechopen.com/embed/renal-tumor/current-perspectives-in-metastatic-renal-cell-carcinoma-treatment-the-role-of-targeted-therapies" />

Embed this code snippet in the HTML of your website to show this chapter

chapter statistics

740total chapter downloads

More statistics for editors and authors

Login to your personal dashboard for more detailed statistics on your publications.

Access personal reporting

Related Content

This Book

Next chapter

New Systemic Treatment Approaches for Metastatic Renal Cell Carcinoma

By Thean Hsiang Tan, Sina Vatandoust and Michail Charakidis

Related Book

First chapter

Diagnostics in Colorectal Surgery

By Murat Ferhat Ferhatoglu and Abdulcabbar Kartal

We are IntechOpen, the world's leading publisher of Open Access books. Built by scientists, for scientists. Our readership spans scientists, professors, researchers, librarians, and students, as well as business professionals. We share our knowledge and peer-reveiwed research papers with libraries, scientific and engineering societies, and also work with corporate R&D departments and government entities.

+3,550 Open Access Books

+57,400 Citations in Web of Science

+108,500 IntechOpen Authors and Academic Editors

+560,000 Unique visitors per month

More about us